MOH
Molina Healthcare Inc
193.30$
+2.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 72.2% | 80.7% | 80.4% | 88.7% | 90.3% | 87.9% | 82.6% | 82.4% | 81.9% | 84.2% | 81.7% | 80.0% | |
| 34.7% | 35.4% | 37.8% | 37.6% | 39.5% | 36.1% | 43.6% | 36.4% | 32.5% | 32.6% | 29.8% | 27.3% | |
| 57.7% | 62.8% | 61.4% | 67.4% | 63.0% | 64.8% | 63.3% | 62.6% | 60.9% | 61.2% | 57.5% | 53.0% | |
| 13.4% | 9.3% | 13.6% | 10.3% | 18.6% | 20.7% | 17.5% | 17.8% | 18.7% | 20.8% | 21.1% | 22.7% | |
| 0.0% | 0.0% | 0.0% | 2.0% | – | -28.7% | -19.7% | -26.2% | – | – | – | – | |
| 7.7% | 6.0% | 6.1% | 4.0% | 3.4% | 5.6% | 3.9% | 3.2% | 2.1% | 2.1% | 2.1% | 1.9% | |
| 6.1% | 7.9% | 8.3% | 2.2% | 2.0% | 2.1% | 7.3% | 8.0% | 9.1% | 8.3% | 10.7% | 12.6% | |
| 2.0% | 1.9% | 1.9% | 0.8% | 0.7% | 0.4% | 2.6% | 2.2% | 2.2% | 1.4% | 1.7% | 1.5% | |
| 77.2% | 76.3% | 77.9% | 84.2% | 77.0% | 71.1% | 78.0% | 78.5% | 75.9% | 71.7% | 71.2% | 73.9% | |
| 49.0% | 58.1% | 61.4% | 65.6% | 59.4% | 48.2% | 52.1% | 57.7% | 55.7% | 54.8% | 50.5% | 47.4% | |
| 0.0% | 6.8% | 6.3% | 7.7% | 3.4% | 0.3% | 28.3% | 0.3% | 0.3% | 0.1% | 0.1% | 0.0% | |
| 5.5% | 5.5% | 5.2% | 4.3% | 5.5% | 7.4% | 6.7% | 6.9% | 7.2% | 8.4% | 8.5% | 7.0% | |
| 15.9% | 14.6% | 13.1% | 15.6% | 14.3% | 18.2% | 22.3% | 17.8% | 17.7% | 14.6% | 18.7% | 24.2% | |
| 22.8% | 23.7% | 22.1% | 15.8% | 23.0% | 28.9% | 22.0% | 21.5% | 24.1% | 28.3% | 28.8% | 26.1% | |
| 13.9% | 11.5% | 10.9% | 3.5% | 14.1% | 26.2% | 19.5% | 19.6% | 22.7% | 26.1% | 26.2% | 23.1% | |
| 1.1% | 0.9% | 0.8% | 0.7% | 0.9% | 0.9% | 0.6% | 0.5% | 0.5% | 0.4% | 0.4% | 0.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.